Showing 8951-8960 of 20387 results for "".
- GLP-1 Receptor Agonists and Dermatologic Outcomes in Type 2 Diabeteshttps://reachmd.com/news/glp-1-dermatologic-outcome-type-2-diabetes/2486945/Key Takeaways Compared with DPP-4 inhibitor initiation, GLP-1 receptor agonist initiation was associated with higher psoriasis risk and lower pemphigus and bullous pemphigoid risk. Other inflammatory or autoimmune skin outcomes were not significantly d
- Diabetes Breakthrough: FDA-Approved Drugs Regenerate Insulin Production in 48 Hourshttps://reachmd.com/news/diabetes-breakthrough-fda-approved-drugs-regenerate-insulin-production-in-48-hours/2456835/We're another step closer to reducing the need for round-the-clock insulin injections to manage diabetes after a new study showed how i
- Redefining COPD Care: Targeting Type 2 Inflammation and Mitigating Vaping Riskshttps://reachmd.com/news/redefining-copd-care-targeting-type-2-inflammation-and-mitigating-vaping-risks/2475041/Contemporary COPD care is being reshaped by the search for therapies tailored to type 2 inflammation and the urgent need to confront vaping‐related respiratory risks. For patients with persistent eosinophilic inflammation, a recent tri
- Study Links Small Pancreas Size to Faster Progression to Stage 3 Type 1 Diabeteshttps://reachmd.com/news/study-links-small-pancreas-size-to-faster-progression-to-stage-3-type-1-diabetes/2457171/Graphical Abstract. Credit: Diabetes Care (2023). DOI: 10.2337/dc23-1681 A multicenter, longitudinal study, co-led by
- Glycemic Control and Predicting Diabetes Complications in Older Adultshttps://reachmd.com/news/glycemic-control-and-predicting-diabetes-complications-in-older-adults/2457141/Credit: Unsplash/CC0 Public Domain Hemoglobin A1c (HbA1c) level plays an important role in type 2 diabetes (T2D) treatment,
- Leptin's New Role in Diabetic Ketoacidosis Management: Beyond Insulinhttps://reachmd.com/news/leptins-new-role-in-diabetic-ketoacidosis-management-beyond-insulin/2476005/Emerging early-stage research suggests leptin may play a role in managing diabetic ketoacidosis (DKA), but its safety and efficacy compared to insulin require further clinical validation. DKA remains a frequent cause of hospitalization among individuals with type 1 diabetes, placing
- GLP-1RAs Linked with Reduced Itch Prevalence in Diabetes Cohorthttps://reachmd.com/news/glp-1-receptor-agonists-tied-to-reduced-itch-prevalence-in-diabetes-cohort/2485184/Results from a new retrospective cohort analysis suggest some glucagon-like peptide-1 (GLP-1) receptor agonists are associated with a reduced prevalence of itch the type 2 diabetes mellitus (T2DM), independent of glycemic control.
- Inflammatory Diets During Pregnancy Linked to Higher Offspring Diabetes Riskhttps://reachmd.com/news/inflammatory-diets-during-pregnancy-linked-to-higher-offspring-diabetes-risk/2475490/A recent Danish cohort analysis indicates an association between maternal diets high in inflammatory foods and an increased risk of type 1 diabetes in offspring, suggesting a need to reevaluate prenatal nutritional guidance. According
- Lifestyle Interventions and Diabetes Prevention: Planning, Tracking, and Mindful Livinghttps://reachmd.com/news/lifestyle-interventions-and-diabetes-prevention-planning-tracking-and-mindful-living/2474656/Comprehensive lifestyle interventions incorporating strategic planning, progress tracking, and mindfulness are significantly reducing the risk of type 2 diabetes. With evidence indicating that nearly 38% of U.S. adults are affected by
- Exploring the Ocular Benefits of GLP-1 Receptor Agonists in Type 2 Diabetes Managementhttps://reachmd.com/news/exploring-the-ocular-benefits-of-glp-1-receptor-agonists-in-type-2-diabetes-management/2471688/GLP-1 Receptor Agonists: A Novel Protective Agent Against Glaucoma in Diabetic Patients? Recent investigations have highlighted that beyond their well-known effects on glycemic control, GLP-1 receptor agonists may significantly reduce the risk of developing primary